Treatment of Early-Stage (T1 / Small T2) Malignant Neoplasm of the Commissure of Lip
Clinical Scenario
This protocol addresses early-stage lip commissure cancer — specifically T1 or small T2 lesions where the tumour measures 2 cm or smaller in greatest dimension. At this stage, the disease is localised and the clinical management options are well-established.
Early-stage cancer at this site can be treated equally well by surgery or radiation therapy. Small lesions are amenable to direct surgical management with primary closure.
Approach Overview
The treatment approach for this scenario encompasses both locoregional and, where indicated, systemic strategies. Radiotherapy-based approaches — delivered over specific fractionation schedules — are among the options considered, alongside systemic therapy for select disease presentations.
The complete protocol, including full eligibility criteria, treatment sequencing, and all clinical details, is available via the link below.
References
DOI: 10.1017/S0022215116000499
- Early stage cancer can be treated equally well by surgery or radiation therapy.
- Small lesions are managed by simple surgical excision and primary closure.
- Palliative RT may be used, either over short fractionation schedules or split course, for patients with advanced and inoperable disease, or those who are not fit for a more toxic, radical approach.
- Palliative chemotherapy should be considered for inoperable, recurrent and or metastatic disease, when possible patients should be offered entry to clinical trials.
View source ↗